secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2023-03-06T23:59:59+00:00
Accession:  0001193125-23-060785
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants eFFECTOR Therapeutics additional 180 days to regain $1 bid price compliance
--------------------------------------------------------------------------------

- Received Nasdaq letter on Feb 28, 2023, extending compliance deadline to Aug 28, 2023.
- Previously had until Feb 27, 2023, to meet minimum $1.00 closing bid price requirement.
- Company may pursue a reverse stock split (if stockholder-approved) to regain compliance.
- If not compliant by Aug 28, 2023, Nasdaq will issue delisting notice; appeal rights exist.
- No assurance of regaining compliance or maintaining other Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523060785/0001193125-23-060785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523060785/d473405d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-060785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer